绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02480 绿竹生物-B

休市中 12-05 09:04:20

23.200

+0.000

0.00%

最高23.200	最低23.200	成交量0.00
今开23.200	昨收23.200	日振幅0.00%
总市值46.17亿	流通市值46.17亿	总股本1.99亿
成交额0.00	换手率0.00%	流通股本1.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02480","market":"HK","secType":"STK","nameCN":"绿竹生物-B","latestPrice":23.2,"timestamp":1764896660457,"preClose":23.2,"halted":0,"volume":0,"delay":0,"floatShares":199000000,"shares":199000000,"eps":-0.918269398523985,"marketStatus":"休市中","change":0,"latestTime":"12-05 09:04:20","open":23.2,"high":23.2,"low":23.2,"amount":0,"amplitude":0,"askPrice":23.2,"askSize":6200,"bidPrice":23.02,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":-0.747804422781696,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":1683475200000,"exchange":"SEHK","adjPreClose":23.2,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02480","defaultTab":"news","newsList":[{"id":"1179582648","title":"北京绿竹生物技术（02480）11月无新增发行 股本结构维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1179582648","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179582648?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:07","pubTimestamp":1764580049,"startTime":"0","endTime":"0","summary":"北京绿竹生物技术股份有限公司于2025年12月1日发布11月股份变动月报表，报告期为截至2025年11月30日。公告显示，公司已发行股本维持不变，普通股H股数量合计202,449,032股，其中包括198,913,232股已发行股份及3,535,800股库存股份。公告同时强调，公司已根据香港联合交易所有限公司的相关上市规则以及相关法律法规安排本月股本变动及信息披露事宜，并由联席公司秘书刘斯宇签署确认。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02480"],"gpt_icon":0},{"id":"2586294747","title":"绿竹生物-B盘中异动 早盘急速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586294747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586294747?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:46","pubTimestamp":1764121567,"startTime":"0","endTime":"0","summary":"2025年11月26日早盘09时46分，绿竹生物-B股票出现异动，股价急速下挫5.09%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为0.39%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126094607a711be40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126094607a711be40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2581412450","title":"绿竹生物-B盘中异动 下午盘大幅拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581412450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581412450?lang=zh_cn&edition=full","pubTime":"2025-11-06 14:55","pubTimestamp":1762412108,"startTime":"0","endTime":"0","summary":"2025年11月06日下午盘14时55分，绿竹生物-B股票出现波动，股价急速拉升5.36%。绿竹生物-B股票所在的生物技术行业中，整体跌幅为0.75%。绿竹生物-B公司简介：北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106145509a6e52a16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106145509a6e52a16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2576094358","title":"绿竹生物-B盘中异动 临近收盘股价大跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576094358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576094358?lang=zh_cn&edition=full","pubTime":"2025-10-17 15:44","pubTimestamp":1760687051,"startTime":"0","endTime":"0","summary":"2025年10月17日临近收盘15时44分，绿竹生物-B股票出现异动，股价快速下跌5.74%。绿竹生物-B股票所在的生物技术行业中，整体跌幅为1.83%。其相关个股中，药捷安康-B、轩竹生物-B、三叶草生物-B涨幅较大，振幅较大的相关个股有永泰生物-B股权、药捷安康-B、轩竹生物-B，振幅分别为57.35%、33.47%、20.55%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101715441194ceaee8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101715441194ceaee8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2574156703","title":"绿竹生物-B(02480)于美国成功完成LZ901的I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2574156703","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574156703?lang=zh_cn&edition=full","pubTime":"2025-10-09 19:05","pubTimestamp":1760007922,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿竹生物-B 公布，于美利坚合众国进行的 LZ901的I期临床试验已于2025年9月成功完成。根据于美国进行的LZ901的I期临床试验结果，LZ901疫苗高剂量组和低剂量组较安慰剂组而言，均表现出良好的安全性和免疫原性。LZ901于中华人民共和国的III期临床试验已达到临床预设目标，并取得符合预期的临床结果。截至本公告日期，LZ901的生物制品许可申请已获中国国家药品监督管理局受理，目前正在接受评估。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2570202067","title":"绿竹生物-B(02480)：彭玲获委任为公司副总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2570202067","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570202067?lang=zh_cn&edition=full","pubTime":"2025-09-25 17:15","pubTimestamp":1758791725,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿竹生物-B(02480)发布公告，公司执行董事、副董事长彭玲女士已获委任为公司副总经理。作为公司副总经理，彭玲女士将主要负责集团各项目的质量研究、质量控制及质量保证工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2566632589","title":"迫近现金红线核心品种难挑大梁，绿竹生物-B(02480)何时重返市场聚光灯下？","url":"https://stock-news.laohu8.com/highlight/detail?id=2566632589","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566632589?lang=zh_cn&edition=full","pubTime":"2025-09-11 17:06","pubTimestamp":1757581609,"startTime":"0","endTime":"0","summary":"8月18日和19日，绿竹生物连续2个交易日收涨逾8%，期间最高股价触及28港元，创下公司股价近15个月以来的新高。即使此次公司核心品种披露重大利好，绿竹生物在8月19日的单日成交量仅为69600股，但这也是其8月至今的最高单日成交量。从成交量来看，绿竹生物依旧处在被市场遗忘的边缘。财报显示，绿竹生物当期现金及现金等价物合计9921.9万元，同比减少29.20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1344132.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2565025556","title":"绿竹生物-B盘中异动 快速跳水7.52%报23.120港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565025556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565025556?lang=zh_cn&edition=full","pubTime":"2025-09-05 15:00","pubTimestamp":1757055600,"startTime":"0","endTime":"0","summary":"2025年09月05日下午盘15时00分，绿竹生物-B股票出现异动，股价大幅下挫7.52%。截至发稿，该股报23.120港元/股，成交量1.32万股，换手率0.01%，振幅7.60%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为5.89%。其相关个股中，宜明昂科-B、欧康维视生物-B、康诺亚-B涨幅较大，振幅较大的相关个股有欧康维视生物-B、宜明昂科-B、君实生物，振幅分别为16.20%、14.72%、13.82%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905150000a4b596ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905150000a4b596ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"1100387642","title":"异动解读 | 绿竹生物-B盘中大涨9.47%，中期业绩亏损收窄近三成","url":"https://stock-news.laohu8.com/highlight/detail?id=1100387642","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100387642?lang=zh_cn&edition=full","pubTime":"2025-08-26 16:40","pubTimestamp":1756197623,"startTime":"0","endTime":"0","summary":"绿竹生物-B今日盘中大涨9.47%，引起市场广泛关注。该股价的显著上涨与公司最新发布的中期业绩报告密切相关。根据绿竹生物-B发布的截至2025年6月30日止六个月业绩报告，公司净亏损为7757万元人民币，同比收窄29.4%。尽管公司仍处于亏损状态，但亏损幅度的显著收窄被投资者视为积极信号。分析人士指出，尽管绿竹生物-B的收入有所下降，但净亏损的大幅收窄表明公司在成本控制和运营效率方面可能取得了进展。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02480"],"gpt_icon":0},{"id":"1131486512","title":"异动解读 | 绿竹生物-B发布中期业绩显改善，盘中大涨9.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131486512","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131486512?lang=zh_cn&edition=full","pubTime":"2025-08-26 16:40","pubTimestamp":1756197622,"startTime":"0","endTime":"0","summary":"今日盘中，绿竹生物-B（02480.HK）股价大涨9.47%，引起市场广泛关注。\n\n消息面上，绿竹生物-B于今日发布了截至2025年6月30日止的中期业绩报告。报告显示，公司期内其他收入为485万元人民币，同比下降50.2%；净亏损为7757万元人民币，同比收窄29.4%；每股基本亏损0.39元人民币。\n\n尽管公司仍处于亏损状态，但净亏损同比大幅收窄近30%，这表明公司的经营状况正在逐步改善。投资者可能对绿竹生物-B的未来发展前景持乐观态度，推动了股价的上涨。然而，投资者仍需密切关注公司后续的经营表现和行业发展动向。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02480"],"gpt_icon":0},{"id":"2562778683","title":"绿竹生物-B(02480)发布中期业绩，净亏损7757万元，同比收窄29.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562778683","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562778683?lang=zh_cn&edition=full","pubTime":"2025-08-26 16:35","pubTimestamp":1756197322,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿竹生物-B 发布截至2025年6月30日止六个月业绩，其他收入485万元，同比下降50.2%;净亏损7757万元，同比收窄29.4%;每股基本亏损0.39元。于2025年上半年，公司已实现多项公司重大里程碑。2025年1月，集团就其核心产品LZ901向国家药监局提交生物制品许可申请，随后于2025年2月获受理。此外，于2025年上半年，集团亦成功完成了LZ901头对头比较研究。董事会相信，该等正面成果为LZ901未来的商业化奠定坚实的基础。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1335247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"1116360898","title":"港股生物医药B类股盘初活跃，创胜集团涨超14%，绿竹生物涨近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116360898","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116360898?lang=zh_cn&edition=full","pubTime":"2025-08-19 09:48","pubTimestamp":1755568113,"startTime":"0","endTime":"0","summary":"8月19日（周二），港股$生物(000504)$医药B类股盘初活跃，创胜集团涨超14%，绿竹生物涨近10%，$启明医疗(02500)$、$科伦博泰(06990)$生物涨超6%，$来凯医药(02105)$、和誉涨超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3c69330474cfca501aba698b1d21b7cf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","02500","BK4614","07226","02480","BK1161","06628"],"gpt_icon":0},{"id":"2560978987","title":"绿竹生物-B(02480)：LZ901头对头比较研究的积极临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2560978987","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560978987?lang=zh_cn&edition=full","pubTime":"2025-08-18 07:52","pubTimestamp":1755474729,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿竹生物-B 发布公告，集团核心产品LZ901与重组糖蛋白E亚单位疫苗HZ/su疫苗进行头对头比较的一项随机、主动对照及非劣效性试验，在50岁及以上成人中获得了积极的免疫原性和安全性数据。该研究招募了301名50岁或以上健康成人，其中至少291名健康成人接种了两剂 LZ901或HZ/su疫苗。截至本公告日期，LZ901的生物制品许可申请已获中华人民共和国国家药品监督管理局受理，目前正在评审中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2aff25c238125730bc7536591e12b53f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"绿竹生物-B(02480)：LZ901头对头比较研究的积极临床数据","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2558639360","title":"绿竹生物-B盘中异动 下午盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558639360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558639360?lang=zh_cn&edition=full","pubTime":"2025-08-11 13:13","pubTimestamp":1754889188,"startTime":"0","endTime":"0","summary":"2025年08月11日下午盘13时13分，绿竹生物-B股票出现波动，股价大幅上涨5.06%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，中慧生物-B、北海康成-B、三叶草生物-B涨幅较大，振幅较大的相关个股有北海康成-B、三叶草生物-B、中生北控生物科技，振幅分别为36.30%、28.57%、16.47%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113130994dc0f82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113130994dc0f82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2557418073","title":"绿竹生物-B盘中异动 股价大涨5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557418073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557418073?lang=zh_cn&edition=full","pubTime":"2025-08-06 10:26","pubTimestamp":1754447163,"startTime":"0","endTime":"0","summary":"2025年08月06日早盘10时26分，绿竹生物-B股票出现波动，股价快速拉升5.79%。绿竹生物-B股票所在的生物技术行业中，整体跌幅为0.85%。绿竹生物-B公司简介：北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080610260397368562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080610260397368562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2555001415","title":"绿竹生物-B盘中异动 下午盘大幅下跌12.07%报21.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555001415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555001415?lang=zh_cn&edition=full","pubTime":"2025-07-31 15:09","pubTimestamp":1753945746,"startTime":"0","endTime":"0","summary":"2025年07月31日下午盘15时09分，绿竹生物-B股票出现波动，股价急速下挫12.07%。截至发稿，该股报21.500港元/股，成交量2400股，换手率0.00%，振幅13.91%。绿竹生物-B股票所在的生物技术行业中，整体跌幅为1.42%。其相关个股中，创胜集团-B、科伦博泰生物-B、锦欣生殖涨幅较大，振幅较大的相关个股有奥星生命科技、中国抗体-B、创胜集团-B，振幅分别为22.50%、19.32%、14.16%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073115090697297d86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073115090697297d86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2555066083","title":"绿竹生物-B盘中异动 早盘急速上涨5.96%报24.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555066083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555066083?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:57","pubTimestamp":1753754248,"startTime":"0","endTime":"0","summary":"2025年07月29日早盘09时57分，绿竹生物-B股票出现异动，股价大幅拉升5.96%。截至发稿，该股报24.000港元/股，成交量1600股，换手率0.00%，振幅4.42%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为1.22%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095728a468a035&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095728a468a035&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2552748365","title":"绿竹生物-B(02480)7月17日斥资684.07万港元回购31.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2552748365","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552748365?lang=zh_cn&edition=full","pubTime":"2025-07-17 18:37","pubTimestamp":1752748627,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿竹生物-B(02480)发布公告，于2025年7月17日，该公司斥资684.07万港元回购31.66万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1319063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2552337694","title":"绿竹生物-B盘中异动 早盘急速下跌7.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552337694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552337694?lang=zh_cn&edition=full","pubTime":"2025-07-17 11:24","pubTimestamp":1752722690,"startTime":"0","endTime":"0","summary":"2025年07月17日早盘11时24分，绿竹生物-B股票出现波动，股价急速下挫7.52%。截至发稿，该股报20.900港元/股，成交量7600股，换手率0.00%，振幅7.52%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为4.92%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071711245097a93634&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071711245097a93634&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2551549951","title":"绿竹生物-B盘中异动 股价大涨5.12%报22.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551549951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551549951?lang=zh_cn&edition=full","pubTime":"2025-07-15 15:57","pubTimestamp":1752566235,"startTime":"0","endTime":"0","summary":"2025年07月15日临近收盘15时57分，绿竹生物-B股票出现异动，股价快速上涨5.12%。截至发稿，该股报22.600港元/股，成交量800股，换手率0.00%，振幅1.40%。资金方面，该股资金流入9010港元，流出4460港元。绿竹生物-B股票所在的生物技术行业中，整体涨幅为3.24%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715155715a44bbf31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715155715a44bbf31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://luzhubiotech.com","stockEarnings":[{"period":"1week","weight":-0.0026},{"period":"1month","weight":0.1111},{"period":"3month","weight":-0.0349},{"period":"6month","weight":-0.0169},{"period":"1year","weight":0.0427},{"period":"ytd","weight":0.0109}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京绿竹生物技术股份有限公司是一家主要从事疫苗及治疗性生物制剂的研究、开发及生产的中国公司。该公司还从事开发创新型人用疫苗及治疗性生物制剂，以预防及控制传染病以及治疗癌症及自身免疫性疾病。该公司的产品包括临床阶段的在研产品，以及临床前阶段的在研产品。核心产品LZ901，主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司主要在国内市场开展其业务","exchange":"SEHK","name":"绿竹生物-B","nameEN":"LUZHU BIOTECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿竹生物-B(02480)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿竹生物-B,02480,绿竹生物-B股票,绿竹生物-B股票老虎,绿竹生物-B股票老虎国际,绿竹生物-B行情,绿竹生物-B股票行情,绿竹生物-B股价,绿竹生物-B股市,绿竹生物-B股票价格,绿竹生物-B股票交易,绿竹生物-B股票购买,绿竹生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿竹生物-B(02480)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}